INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,581,000 | -22.5% | 50,000 | 0.0% | 0.17% | -20.9% |
Q2 2023 | $2,039,000 | +13.2% | 50,000 | 0.0% | 0.22% | +8.6% |
Q1 2023 | $1,801,000 | +3.2% | 50,000 | 0.0% | 0.20% | +8.8% |
Q4 2022 | $1,744,500 | -33.9% | 50,000 | 0.0% | 0.18% | -34.1% |
Q3 2022 | $2,639,000 | +2.0% | 50,000 | 0.0% | 0.28% | -6.1% |
Q2 2022 | $2,588,000 | -28.8% | 50,000 | 0.0% | 0.29% | -18.1% |
Q1 2022 | $3,634,000 | – | 50,000 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |